8:00-9:15

Breakfast and Morning walk in the Garden, optional.

9:15-10:00

Plenary Session 2

Diabetes: quo vadis?

Carine de Beaufort (Pediatric diabetologist-endocrinologist at DECCP/Clinique Pediatrique de Luxembourg-CHL and Guest Professor at Faculty of Science, Technology and Medicine, Université of Luxembourg, Esch-Belval Luxembourg)

Chair: Konstantinos Makrilakis, Laiko General Hospital, Internal Medicine / University of Athens, Medical School, Greece

10:00-10:45

Poster Pitches & Boards, session 2: Infections & Quality of care

Chair: Stavros Liatis, Laiko General Hospital, University of Athens, Greece

Max. 2 min. poster pitches in the main hall, followed by ~40 minutes of questions/discussion next to poster boards in reception hall with drinks available

PP&B10

TYPE 1 DIABETES AND SEASONAL INFLUENZA – A SWEDISH NATIONAL DIABETES REGISTER STUDY

Elin Allansson Kjölhede, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden

PP&B11

INFECTIONS AND THE RISK OF LADA AND TYPE 2 DIABETES

Jessica Edstorp, Karolinska institutet, Institute of Environmental Medicine, Sweden

PP&B12

DIABETES AND RISK OF HOSPITALISATION DUE TO INFECTION IN NORTHEASTERN THAILAND: RETROSPECTIVE COHORT STUDY OF NATIONAL HEALTHCARE SERVICE DATA

Sarah Wild, University of Edinburgh, Usher Institute, United Kingdom

PP&B13

PROJECTED PREVALENCE OF DIABETES MELLITUS DUE TO INCREASED INCIDENCE ATTRIBUTABLE TO THE COVID-19 PANDEMIC IN THE U.S.

Jiancong Wang, German Diabetes Center (DDZ), Institute for Biometrics and Epidemiology, Germany

PP&B14

EXCESS MORTALITY DUE TO DIABETES DURING THE COVID-19 PANDEMIC IN COLOMBIA. AN ECOLOGICAL STUDY. AN ANALYSIS OF THE REFRECA PROJECT

Juan Pablo Pérez Bedoya, University of Antioquia, Epidemiology, Colombia

PP&B15

IMPACT OF THE COVID-19 PANDEMIC IN THE NETHERLANDS ON PRIMARY HEALTH CARE USE AND CLINICAL OUTCOMES IN PEOPLE WITH TYPE 2 DIABETES

Jesse M. van den Berg, Amsterdam UMC, General Practice, The Netherlands

PP&B16

DIABETES IN GREENLAND: HIGHER QUALITY OF CARE IN CENTRAL REGIONAL TOWNS COMPARED TO SMALLER TOWNS.

Marie Balslev Backe, Steno Diabetes Center Greenland, Greenland

PP&B17

CHANGES IN WEIGHT, QUALITY OF LIFE AND PSYCHOPATHOLOGY UNTIL 3 YEARS AFTER BARIATRIC SURGERY IN PEOPLE WITH AND WITHOUT TYPE 2 DIABETES

Isabel Slurink, Tilburg University, Department of Medical and Clinical Psychology, The Netherlands

PP&B18

PSYCHOMETRIC PROPERTIES AND IMPLEMENTATION OF SEVEN PROMIS COMPUTERIZED ADAPTIVE TESTS IN PEOPLE WITH TYPE 2 DIABETES

Femke Rutters, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

PP&B19

REAL WORLD DATA ON DIABETES IMPACT AND DEVICE SATISFACTION USING AUTOMATED AND NONAUTOMATED INSULIN DELIVERY SYSTEMS IN CHILDREN WITH TYPE 1 DIABETES

Valentino Cherubini, Dept. of Pediatrics, Azienda ospedaliero-Universitaria delle Marche, Italy

10:45-11:00

Tea/coffee break

11:00-12:00

Oral Presentations, session 3: Diabetes management

Chairs:

Marieke Blom, Amsterdam UMC, General Practice, The Netherlands

Adam Hulman, Steno Diabetes Center Aarhus, Denmark

10 min.  presentations + 5 min. discussion

OP9

COST-EFFECTIVENESS OF SGLT2 INHIBITORS IN A REAL-WORLD POPULATION: A MICADO MODEL-BASED ANALYSIS USING ROUTINE DATA FROM A GP REGISTRY

Xinyu Li, University of Groningen, The Netherlands

OP10

EFFECTIVENESS AND SAFETY OF SECOND-GENERATION BASAL INSULINS IN NAÏVE USERS
WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: A DANISH REGISTER-BASED COHORT STUDY

Vanja Kosjerina, Steno Diabetes Center Copenhagen, Denmark

OP11

DIET IN THE MANAGEMENT OF TYPE 2 DIABETES: AN UMBRELLA REVIEW OF THE EVIDENCE

Edyta Szczerba, German Diabetes Center, Germany

OP12

PREVALENCE OF SEXUAL DYSFUNCTION IN TYPE 1 AND TYPE 2 DIABETES – A CROSS-SECTIONAL QUESTIONAIRE SURVEY FROM THE HEALTH IN CENTRAL DENMARK COHORT

Lasse Bjerg, Aarhus University Hospital, Steno Diabetes Center Aarhus, Denmark

12:00-13:00

Lunch

13:00-14:00

Oral Presentations, session 4: Diabetes complications

Chairs:

Dorte Vistisen, Steno Diabetes Center Copenhagen, Clinical Research, Denmark

Sharon Remmelzwaal, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

10 min.  presentations + 5 min. discussion

OP13

THE IMPACT OF DIABETES ASSOCIATED RISK FACTORS ON SURVIVAL AMONG INDIVIDUALS WITH TYPE 2 DIABETES AND BREAST-, LUNG-, COLORECTAL- OR PROSTATE CANCER

Tinne Laurberg, Steno Diabetes Center Aarhus, Denmark

OP14

PREDICTED LIFE COURSE OF INDIVIDUALS WITH TYPE 2 DIABETES AND NEPHROPATHY AT STENO DIABETES CENTER COPENHAGEN FROM 2001 TO 2020

Kristin Jesse, Steno Diabetes Center Copenhagen, Clinical Epidemiological Research, Denmark

OP15

HIGHER MORTALITY RISK WITH CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES ESPECIALLY IN YOUNGER AGES: A DANISH NATIONWIDE COHORT STUDY

Martin Erik Nyeland, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Denmark

OP16

THE IMPACT OF DIABETES TYPE AND GENDER ON TRENDS IN CAUSES OF DEATH AND YEARS-LOST IN DENMARK, 2002-2019

Henrik Støvring, Steno Diabetes Center Aarhus, Denmark

14:00-15:00

Plenary Session 3

Genetics of Obesity and Thinness

Sadaf Farooqi (MD, Endocrinologist and principal investigator at Cambridge University, MRC institue of metabolic science, Cambridge, United Kingdom)

Chair: Francis Finucane, Bariatric Medicine Service, Centre for Diabetes, Endocrinology and Metabolism, Galway University Hospitals, Ireland

15:00-19:30

Social outing

Cultural, Energizing, Fun: a visit to the most beautiful spring garden in the world: Keukenhof.

Take a leisurely stroll through the garden that not only provides a backdrop for its 7 million spring-flowering bulbs, but also has sculptures and other works of art that give the park an added dimension. Keukenhof is collaborating with 25 artists. The combination of a flowering park and visual art is amazing.

Keukenhof website

19:30-21:00

Dinner

21:00-22:00

EDEG Pub-Quiz

Team allocation is cluster randomised, so come and support your new team mates!